- Home
- LGHL vs CPHI Comparison
LGHL vs CPHI Comparison
Compare LGHL & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGHL
- CPHI
- Stock Information
- Founded
- LGHL 2015
- CPHI N/A
- Country
- LGHL Singapore
- CPHI China
- Employees
- LGHL N/A
- CPHI N/A
- Industry
- LGHL Investment Bankers/Brokers/Service
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- LGHL Finance
- CPHI Health Care
- Exchange
- LGHL Nasdaq
- CPHI Nasdaq
- Market Cap
- LGHL 4.3M
- CPHI 4.0M
- IPO Year
- LGHL N/A
- CPHI N/A
- Fundamental
- Price
- LGHL $0.14
- CPHI $0.21
- Analyst Decision
- LGHL
- CPHI
- Analyst Count
- LGHL 0
- CPHI 0
- Target Price
- LGHL N/A
- CPHI N/A
- AVG Volume (30 Days)
- LGHL 2.7M
- CPHI 1.6M
- Earning Date
- LGHL 02-11-2025
- CPHI 03-31-2025
- Dividend Yield
- LGHL N/A
- CPHI N/A
- EPS Growth
- LGHL N/A
- CPHI N/A
- EPS
- LGHL N/A
- CPHI N/A
- Revenue
- LGHL $13,659,110.00
- CPHI $5,544,620.00
- Revenue This Year
- LGHL N/A
- CPHI N/A
- Revenue Next Year
- LGHL N/A
- CPHI N/A
- P/E Ratio
- LGHL N/A
- CPHI N/A
- Revenue Growth
- LGHL 11.35
- CPHI N/A
- 52 Week Low
- LGHL $0.13
- CPHI $0.13
- 52 Week High
- LGHL $1.55
- CPHI $0.60
- Technical
- Relative Strength Index (RSI)
- LGHL 42.74
- CPHI 47.80
- Support Level
- LGHL $0.14
- CPHI $0.19
- Resistance Level
- LGHL $0.18
- CPHI $0.26
- Average True Range (ATR)
- LGHL 0.02
- CPHI 0.03
- MACD
- LGHL -0.00
- CPHI -0.00
- Stochastic Oscillator
- LGHL 21.49
- CPHI 31.63
About LGHL Lion Group Holding Ltd.
Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.